ERBB2 and breast carcinoma: Using IPP, we also identified prognostic genes specific for subtypes of breast cancer that are differentiated by receptor type, i.e., luminal (ER+/PR+), HER2-enriched (ER-/PR-/HER2+), and triple-negative (ER-/PR-/HER2-)22.